Trend of clinical drug trials in type 2 diabetes mellitus over last decade | Zendy

Rakesh Parikh | Zendy; Kirti Pandia | Zendy; Mahesh Goyal | Zendy; Meenakshi Sharma | Zendy; MS Dolima | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Trend of clinical drug trials in type 2 diabetes mellitus over last decade

Author(s) -

Rakesh Parikh,

Kirti Pandia,

Mahesh Goyal,

Meenakshi Sharma,

MS Dolima

Publication year - 2011

Publication title -

perspectives in clinical research

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.649

H-Index - 8

eISSN - 2229-5488

pISSN - 2229-3485

DOI - 10.4103/2229-3485.80369

Subject(s) - medicine , clinical trial , drug , population , type 2 diabetes mellitus , type 2 diabetes , diabetes mellitus , china , drug trial , pharmacology , environmental health , endocrinology , geography , archaeology

Type 2 diabetes mellitus (Type 2 DM) has been recognized as the recent pandemic; India and China competing each other for the title-"Diabetes Capital of the World." A number of new drugs have been recently available and has lead to a boom in the clinical drug trial industry. We intend to evaluate the trend of clinical drug trials in Type 2 DM over last one decade.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research